Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baohui Han

Showing results (61-70 of 426) with videos related to

Pageof 43
Sort By:
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 19, 2014
[Quantization Methodology of Autofluorescence Bronchoscopy Image 
in the YUV System]Xiaoxuan Zheng, Hongkai Xiong, Yong Li, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 21, 2010
[Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer.]Tianqing Chu, Hao Lin, Jie Shen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 19, 2013
[Analysis of prognostic factors in patients with stage IV lung adenocarcinoma after failure of second-line EGFR-TKIs therapy]Shujun Dai, Youru Liu, Lin Wang, et al.
Biochemical and Biophysical Research Communications|December 24, 2013
Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiationTianqing Chu, Jiajun Teng, Liyan Jiang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 20, 2011
[Pemetrexed alone versus pemetrexed combined with oxaliplatin as salvage therapy in stage IV lung adenocarcinoma]Youru Liu, Yinling Jiang, Zhiqiang Gao, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 21, 2010
[Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer: A Report of 92 Eases.]Aiqin Gu, Liwen Xiong, Huimin Wang, et al.
Frontiers in Oncology|September 13, 2021
Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung CancerLian Yu, Jianlin Xu, Rong Qiao, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|March 8, 2003
[The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer]Baohui Han, Meilin Liao, Jianzhong Su, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 2, 2013
Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancerAiqin Gu, Chunlei Shi, Liwen Xiong, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 23, 2012
[Effects of EGFR-TKIs on sequential pemetrexed
for advanced pulmonary adenocarcinoma]Xiangying Wang, Youru Liu, Zhiqiang Gao, et al.
Pageof 43

Showing results (61-70 of 426) with videos related to

Sort By:
Pageof 43
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|November 19, 2014
[Quantization Methodology of Autofluorescence Bronchoscopy Image 
in the YUV System]Xiaoxuan Zheng, Hongkai Xiong, Yong Li, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 21, 2010
[Comparison of the Clinical Effects of Paclitaxel and Paclitaxel plus Oxaliplatin as the Second-line Treatment of Advanced Non-small Cell Lung Cancer.]Tianqing Chu, Hao Lin, Jie Shen, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|January 19, 2013
[Analysis of prognostic factors in patients with stage IV lung adenocarcinoma after failure of second-line EGFR-TKIs therapy]Shujun Dai, Youru Liu, Lin Wang, et al.
Biochemical and Biophysical Research Communications|December 24, 2013
Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiationTianqing Chu, Jiajun Teng, Liyan Jiang, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 20, 2011
[Pemetrexed alone versus pemetrexed combined with oxaliplatin as salvage therapy in stage IV lung adenocarcinoma]Youru Liu, Yinling Jiang, Zhiqiang Gao, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|August 21, 2010
[Clinical Observation of Erlotinib in the Treatment of Advanced Non-small Cell Lung Cancer: A Report of 92 Eases.]Aiqin Gu, Liwen Xiong, Huimin Wang, et al.
Frontiers in Oncology|September 13, 2021
Patterns of Recurrence and Survival Rate After Complete Resection of Pathological Stage N2 Small-Cell Lung CancerLian Yu, Jianlin Xu, Rong Qiao, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|March 8, 2003
[The relationship between drug sensitivity and expression of drug resistance gene mutations in non-small cell lung cancer]Baohui Han, Meilin Liao, Jianzhong Su, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|February 2, 2013
Efficacy and safety evaluation of icotinib in patients with advanced non-small cell lung cancerAiqin Gu, Chunlei Shi, Liwen Xiong, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|May 23, 2012
[Effects of EGFR-TKIs on sequential pemetrexed
for advanced pulmonary adenocarcinoma]Xiangying Wang, Youru Liu, Zhiqiang Gao, et al.
Pageof 43